Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Faucher

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Blood|February 21, 2009
Older age does not influence allogeneic peripheral blood stem cell mobilization in a donor population of mostly white ethnic originHugues de Lavallade, Patrick Ladaique, Claude Lemarié, et al.
International Journal of Antimicrobial Agents|December 29, 2007
Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients: PROPHYSOME StudyCatherine Cordonnier, Mohamad Mohty, Catherine Faucher, et al.
British Journal of Haematology|April 14, 2016
Low incidence of chronic GVHD after HLA-haploidentical peripheral blood stem cell transplantation with post-transplantation cyclophosphamide in older patientsRaynier Devillier, Angela Granata, Sabine Fürst, et al.
Bulletin Du Cancer|December 13, 2024
[Medical simulation training for bone marrow harvesting from a healthy donor for an allogeneic hematopoietic cell transplant (SFGM-TC)]Tamim Alsuliman, Leonardo Magro, Marie Titecat, et al.
Leukemia & Lymphoma|July 16, 2010
Impact of prior invasive aspergillosis on outcome in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantJean El-Cheikh, Luca Castagna, Ling Wang, et al.
Blood|September 6, 2005
Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantationMohamad Mohty, Didier Blaise, Catherine Faucher, et al.
Hematology/Oncology and Stem Cell Therapy|December 15, 2010
Once-weekly liposomal amphotericin B for prophylaxis of invasive fungal infection after graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: a comparative retrospective single-center studyJean El Cheikh, Luca Castagna, Ling Wang, et al.
American Journal of Hematology|January 31, 2017
Impact of CD34-positive cell dose on outcome after peripheral blood stem cell allogeneic transplantation prepared with ATG-based reduced intensity conditioning regimenAude Collignon, Boris Calmels, Samia Harbi, et al.
Mediterranean Journal of Hematology and Infectious Diseases|July 20, 2012
JC Virus Leuko-Encephalopathy in Reduced Intensity Conditioning Cord Blood Transplant Recipient with a Review of the LiteratureJean El-Cheikh, Sabine Fürst, Francois Casalonga, et al.
Bulletin Du Cancer|May 10, 2021
[Definition and standardization of histocompatibility requests depending on patient course and donor type: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) and the Francophone Society of Histocompatibility and Immunogenetics (SFHI)]Valérie Dubois, Kahina Amokrane, Roberto Crocchiolo, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Blood|February 21, 2009
Older age does not influence allogeneic peripheral blood stem cell mobilization in a donor population of mostly white ethnic originHugues de Lavallade, Patrick Ladaique, Claude Lemarié, et al.
International Journal of Antimicrobial Agents|December 29, 2007
Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients: PROPHYSOME StudyCatherine Cordonnier, Mohamad Mohty, Catherine Faucher, et al.
British Journal of Haematology|April 14, 2016
Low incidence of chronic GVHD after HLA-haploidentical peripheral blood stem cell transplantation with post-transplantation cyclophosphamide in older patientsRaynier Devillier, Angela Granata, Sabine Fürst, et al.
Bulletin Du Cancer|December 13, 2024
[Medical simulation training for bone marrow harvesting from a healthy donor for an allogeneic hematopoietic cell transplant (SFGM-TC)]Tamim Alsuliman, Leonardo Magro, Marie Titecat, et al.
Leukemia & Lymphoma|July 16, 2010
Impact of prior invasive aspergillosis on outcome in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantJean El-Cheikh, Luca Castagna, Ling Wang, et al.
Blood|September 6, 2005
Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantationMohamad Mohty, Didier Blaise, Catherine Faucher, et al.
Hematology/Oncology and Stem Cell Therapy|December 15, 2010
Once-weekly liposomal amphotericin B for prophylaxis of invasive fungal infection after graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: a comparative retrospective single-center studyJean El Cheikh, Luca Castagna, Ling Wang, et al.
American Journal of Hematology|January 31, 2017
Impact of CD34-positive cell dose on outcome after peripheral blood stem cell allogeneic transplantation prepared with ATG-based reduced intensity conditioning regimenAude Collignon, Boris Calmels, Samia Harbi, et al.
Mediterranean Journal of Hematology and Infectious Diseases|July 20, 2012
JC Virus Leuko-Encephalopathy in Reduced Intensity Conditioning Cord Blood Transplant Recipient with a Review of the LiteratureJean El-Cheikh, Sabine Fürst, Francois Casalonga, et al.
Bulletin Du Cancer|May 10, 2021
[Definition and standardization of histocompatibility requests depending on patient course and donor type: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) and the Francophone Society of Histocompatibility and Immunogenetics (SFHI)]Valérie Dubois, Kahina Amokrane, Roberto Crocchiolo, et al.
Pageof 8